Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03120832
Title Phase 1 Trial of PAN-301-1 in Cancer Patients
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Panacea Pharmaceuticals, Inc.
Indications

prostate cancer

Therapies

PAN-301-1

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.